• Pertussis incidence has resurged in the United States (US) after a nadir in the 1970s and is now one of the most prevalent vaccine-preventable infections
• Infants are at greatest risk for severe pertussis-related morbidity and mortality (~50% of infant cases require hospitalization) and account for the majority of cases 1
• Recent surveillance indicates a resurgence of overall pertussis incidence in the US, 2 but limited data exist on the cost and mortality burden of severe infantile cases
OBJECTIVE
• We sought to quantify the cost and mortality burden of infant pertussis cases severe enough to prompt hospitalization
METHODS

Study Design
• Retrospective database analysis
Data Source
• Discharge data from the 2000-2011 Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS)
• The NIS is the largest all-payer inpatient care database in the US
• The NIS includes many variables for each inpatient stay, including demographics, diagnosis codes, length of stay (LOS), total charges, admission, and discharge status • Charges were converted to costs using a 0.5 cost-to-charge ratio • Mean (standard deviation [SD]) LOS for these hospitalizations fl uctuated minimally year to year, but an overall (albeit modest) increase was observed: from 3.3 (7.3) days in 2000 to 3.9 (9.5) days in 2010
• Mean (SD) cost per admission increased at a greater rate than LOS, from $12,377 ($23,985) in 2000 to $16,339 ($37,224) in 2010
• Across the study period, both LOS and costs were nearly double those observed for nonpertussis hospitalizations
Case Fatality Rates (Figure 3)
• Overall CFRs were relatively stable during the period, fl uctuating between ~1.5% and 3%, although a peak of 4.4% occurred in 2005, coinciding with the incidence peak • Because unique patient identifi ers were not provided, we were unable to follow patients who moved from facility to facility; results may be biased somewhat if the experiences of patients who transferred from facility to facility differed from those who remained in the analytic sample
CONCLUSIONS
• Infant pertussis hospitalizations typically exceed 3 days and are associated with high costs compared with hospitalizations for other causes
• Observed CFRs were consistent with the ~2% fatality rate previously derived from surveillance by the Centers for Disease Control and Prevention, although some substantial differences in CFRs by race/ethnicity were noted
• These data may help inform economic and cost-effectiveness evaluations of future pertussis vaccination programs
• The stratifi ed analysis of CFRs by race/ethnicity highlights the need for increased focus on minorities, particularly blacks, in pertussis vaccination programs 3.3 3.4 3.4 3.5 3.6 3.7 3.6 3.7 3.6 3.7 3.9 3.9 5.9 6.8 6.5 
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